Light-Based brain imaging may unlock secrets of infantile seizures
NCT ID NCT02899832
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study uses a non-invasive light-based technique called near-infrared spectroscopy (NIRS) combined with EEG to measure blood flow changes in the brains of children aged 3 to 6 years during infantile epilepsy spasms. The goal is to better understand what happens in the brain before, during, and after these seizures. The research is purely observational and does not test any new treatment.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better understand what happens in the brain during infantile spasms, potentially improving diagnosis and treatment monitoring.
- What could go wrong
- This is a small, early-stage observational study with only 14 children, so results may not apply to all patients. It does not test a treatment, so it will not directly improve outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Amiens
Amiens, 80054, France
-
Fondation Ophtalmologique Rothshild
Paris, 75019, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can community hospitals in zambia master severe disease care?
- Can mindfulness rewire the mind to lift depression in epilepsy?
- A break from seizure pills: could less medication mean better living?
- Can invisible electric fields quiet the Brain's seizure signals?
- Can a new drug tame severe childhood epilepsy?